Clinical trials
We test, we share
By providing accessible clinical trial information, we are committed to helping people - medical practitioners, patients and their families - improving their knowledge of healthcare testing and results. As part of our global transparency policy, we openly publish clinical trial outcomes. Find here basic information on the registration and results of our clinical trials.
Closer to patients
We strive to stay one step ahead in transforming lives, which is why we develop innovative digital applications for patients participating in our clinical studies. Through their mobile devices, patients can share progress with clinical sites, send data, and access interactive content about their disease evolution—conveniently and cost-effectively. They also receive educational resources and healthy lifestyle tips.
Our transparency policy
Almirall is committed to disclosing clinical trial information to be compliant with the format and timelines requirements of the Health Agencies and International Committee of Medical Journal Editors (ICMJE).
Clinical trials will be registered before starting the study by means of public registry databases such as ClinicalTrials.gov and CTIS/EudraCT or any other National registries as required and published in leading biomedical journals.
Summary of results, including Plain Language Summaries will be reported on registries such as ClinicalTrials.gov, European Clinical Trials Database (EudraCT), and/or the EU CTIS. Procedures will be followed to ensure results are reported in compliance with applicable laws and regulations.
Almirall is also committed to disclosing clinical trial information and sharing clinical trial data with independent researchers, patients and healthcare professionals to conform with internationally accepted scientific and ethical standards.
Any clinical data requests should be accompanied by a research protocol proposal and (1) include a commitment to the future publication of the results, (2) ensure anonymity of patient data and (3) respect Almirall's confidential commercial information. Our "Terms of Use" agreement must be signed before clinical data may be accessed. To facilitate clinical study data sharing according to our Transparency Policy, researchers can submit a request by sending a proposal here.
All requests will be reviewed independently on a case-by-case basis.
Good practices in clinical trials, our standard
We carry out our global clinical trials efficiently and to the highest quality standards, following internationally recognized scientific and ethical guidelines. Clinical trials are performed in line with authorities’ requirements in the countries where the trials are performed, as well as following European Directives & Guidelines, such as Good Clinical Practices from the International Conference of Harmonization, and FDA GCP regulations contained in the 21 Code of Federal Regulations.
Medical advice
Please keep in mind that the information on this website is not intended to replace advice from healthcare professionals. Patients should always seek medical advice before starting or changing their treatment. Healthcare professionals should consult the approved labelling for the patient's country to ensure that they receive the most up-to-date and appropriate information according to local requirements.